Ligand ID: RAU


Drugbank ID:
DB01367
(Rasagiline)


Indication:
For the treatment of the signs and symptoms of idiopathic Parkinsons disease as initial monotherapy and as adjunct therapy to levodopa.

Get human targets for RAU in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND 'RAU'

Click here for results that match SARS-Cov-2 / COVID-19 structures only
Click here for results that match SARS-related structures only


1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		1z1j 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
MET A   6
TYR B1126
GLY B1143
LEU B1141
TYR B1118
1.76A23.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		2acf REPLICASE
POLYPROTEIN 1AB
(SARS-COV
Tor2)		5 / 10
SER A 262
GLY A 255
VAL A 277
LEU A 225
TYR A 250
1.72A24.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		2acf REPLICASE
POLYPROTEIN 1AB
(SARS-COV
Tor2)		5 / 10
VAL A 277
LEU A 225
TYR A 250
SER A 262
GLY A 255
1.68A24.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		2acf REPLICASE
POLYPROTEIN 1AB
(SARS-COV
Tor2)		5 / 11
VAL A 277
LEU A 225
TYR A 250
SER A 262
GLY A 255
1.68A24.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		2acf REPLICASE
POLYPROTEIN 1AB
(SARS-COV
Tor2)		5 / 12
SER A 262
GLY A 255
VAL A 277
LEU A 225
TYR A 250
1.68A24.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		2cjr NUCLEOCAPSID PROTEIN
(SARS-COV
TW1)		5 / 11
LEU D 292
PHE D 275
TRP D 302
SER C 319
GLY D 288
1.60A18.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		2cjr NUCLEOCAPSID PROTEIN
(SARS-COV
TW1)		5 / 10
TRP D 302
SER C 319
GLY D 288
LEU D 292
PHE D 275
1.59A18.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		2cjr NUCLEOCAPSID PROTEIN
(SARS-COV
TW1)		5 / 12
TRP D 302
SER C 319
GLY D 288
LEU D 292
PHE D 275
1.60A18.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		2cjr NUCLEOCAPSID PROTEIN
(SARS-COV
TW1)		5 / 10
LEU D 292
PHE D 275
TRP D 302
SER C 319
GLY D 288
1.60A18.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)
(SARSr-CoV)		5 / 10
VAL A  96
LEU A  44
TYR A  69
SER A  81
GLY A  74
1.67A25.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)
(SARSr-CoV)		5 / 10
SER A  81
GLY A  74
VAL A  96
LEU A  44
TYR A  69
1.71A25.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)
(SARSr-CoV)		5 / 12
SER A  81
GLY A  74
VAL A  96
LEU A  44
TYR A  69
1.67A25.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)
(SARSr-CoV)		5 / 11
VAL A  96
LEU A  44
TYR A  69
SER A  81
GLY A  74
1.66A25.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_H_RAUH400_1
(IMINE REDUCTASE)		2ga6 ORF1A POLYPROTEIN
(SARSr-CoV)		5 / 10
MET J  44
SER J  72
GLY I  94
MET I  44
TYR I  96
1.34A18.06
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		2ga6 ORF1A POLYPROTEIN
(SARSr-CoV)		5 / 12
MET J  44
SER J  72
GLY I  94
MET I  44
TYR I  96
1.36A18.06
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		2ga6 ORF1A POLYPROTEIN
(SARSr-CoV)		5 / 11
MET I  44
TYR I  96
MET J  44
SER J  72
GLY I  94
1.36A18.06
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		2ga6 ORF1A POLYPROTEIN
(SARSr-CoV)		5 / 10
MET D  44
TYR D  96
MET C  44
SER C  72
GLY D  94
1.34A18.06
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		2gib NUCLEOCAPSID PROTEIN
(SARSr-CoV)		5 / 10
LEU A 292
PHE A 275
TRP A 302
SER B 319
GLY A 288
1.74A16.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		2h85 PUTATIVE ORF1AB
POLYPROTEIN
(SARSr-CoV)		5 / 10
VAL A 303
TYR A 237
PHE A 221
MET A 209
GLY A 238
1.65A23.16
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_H_RAUH400_1
(IMINE REDUCTASE)		2h85 PUTATIVE ORF1AB
POLYPROTEIN
(SARSr-CoV)		5 / 10
MET A 209
GLY A 238
VAL A 303
TYR A 237
PHE A 221
1.64A23.16
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		2h85 PUTATIVE ORF1AB
POLYPROTEIN
(SARSr-CoV)		5 / 12
MET A 209
GLY A 238
VAL A 303
TYR A 237
PHE A 221
1.65A23.16
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		2h85 PUTATIVE ORF1AB
POLYPROTEIN
(SARSr-CoV)		5 / 11
VAL A 303
TYR A 237
PHE A 221
MET A 209
GLY A 238
1.64A23.16
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		2op9 REPLICASE
POLYPROTEIN 1AB
(PP1AB, ORF1AB)
3C-LIKE PROTEINASE
(3CL-PRO, 3CLP)
(SARSr-CoV)		5 / 12
MET A   6
TYR B 126
GLY B 143
LEU B 141
TYR B 118
1.78A23.94
None
None
WR1  B 602 (-3.3A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		3d0h ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 11
LEU B 222
TYR B 217
MET B 579
GLN B 221
GLY B 220
1.57A18.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		3d0h ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
MET B 579
GLN B 221
GLY B 220
LEU B 222
TYR B 217
1.57A18.91
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		3fzd 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
TYR A 161
SER A 147
GLY A  29
VAL A 114
LEU A  30
1.45A24.01
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		3i6k HLA, A-2
(Homo
sapiens)		5 / 12
TYR E  59
MET E   5
GLY E 100
VAL E  34
TYR E 159
1.65A18.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		3i6l BETA-2-MICROGLOBULIN
HLA, A-24
(Homo
sapiens)		5 / 10
LEU D 206
TRP D 204
MET E  99
SER E  11
GLY D 207
1.80A20.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		3i6l BETA-2-MICROGLOBULIN
HLA, A-24
(Homo
sapiens)		5 / 11
LEU D 206
TRP D 204
MET E  99
SER E  11
GLY D 207
1.78A20.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		3i6l BETA-2-MICROGLOBULIN
HLA, A-24
(Homo
sapiens)		5 / 12
TRP D 204
MET E  99
SER E  11
GLY D 207
LEU D 206
1.79A20.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		3sci ACE2
(Homo
sapiens)		5 / 12
MET B 579
GLN B 221
GLY B 220
LEU B 222
TYR B 217
1.65A19.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		3sci ACE2
(Homo
sapiens)		5 / 11
LEU B 222
TYR B 217
MET B 579
GLN B 221
GLY B 220
1.64A19.33
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		3sck ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 11
LEU B 222
TYR B 217
MET B 579
GLN B 221
GLY B 220
1.48A18.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		3sck ACE2
(Paguma
larvata;
Homo
sapiens;
SARSr-CoV)		5 / 12
MET B 579
GLN B 221
GLY B 220
LEU B 222
TYR B 217
1.49A18.93
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		4ovz PAPAIN-LIKE
PROTEINASE
(SARS-COV
Urbani)		5 / 12
GLN A 233
GLY A 220
VAL A 185
LEU A 217
TYR A 208
1.70A21.78
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		4ow0 PAPAIN-LIKE PROTEASE
(SARS-COV
Urbani)		5 / 10
GLN A 233
GLY A 220
VAL A 185
LEU A 217
TYR A 208
1.78A21.78
GOL  A 904 (-2.4A)
None
None
None
GOL  A 904 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		4ow0 PAPAIN-LIKE PROTEASE
(SARS-COV
Urbani)		5 / 11
VAL A 185
LEU A 217
TYR A 208
GLN A 233
GLY A 220
1.72A21.78
None
None
GOL  A 904 ( 4.5A)
GOL  A 904 (-2.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		5b6o 3C-LIKE PROTEINASE
(SARSr-CoV)		5 / 12
MET A   6
TYR B 126
GLY B 143
LEU B 141
TYR B 118
1.75A23.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		5c8u GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 10
VAL D 199
MET D  62
PHE D  73
MET D  72
GLY D  59
1.72A21.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		5c8u GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 11
VAL D 199
MET D  62
PHE D  73
MET D  72
GLY D  59
1.71A21.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		5c8u GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 12
MET D  72
GLY D  59
VAL D 199
MET D  62
PHE D  73
1.72A21.04
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 10
VAL C 199
LEU C 185
MET C 241
MET C  72
GLY C  88
1.74A20.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 12
MET C  72
GLY C  88
VAL C 199
LEU C 185
MET C 241
1.74A20.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 11
VAL C 199
LEU C 185
MET C 241
MET C  72
GLY C  88
1.74A20.46
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		5tl7 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 11
VAL B 185
LEU B 217
TYR B 208
GLN B 233
GLY B 220
1.71A21.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		5tl7 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 12
GLN B 233
GLY B 220
VAL B 185
LEU B 217
TYR B 208
1.71A21.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		5tl7 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		5 / 10
GLN B 233
GLY B 220
VAL B 185
LEU B 217
TYR B 208
1.76A21.88
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		5x58 SPIKE GLYCOPROTEIN
(SARS-COV
BJ01)		5 / 12
TYR C 677
SER C 659
VAL C 675
LEU C 636
TYR C 598
1.77A13.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		5y3q REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		5 / 12
GLN A 233
GLY A 220
VAL A 185
LEU A 217
TYR A 208
1.75A19.61
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6acj SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 12
MET C 417
TYR C 367
GLN C 401
GLY C 403
VAL C 420
1.39A13.38
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6crx SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 12
MET A 417
TYR A 367
GLN A 401
GLY A 403
VAL A 420
1.44A13.58
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6jyt HELICASE
(SARSr-CoV)		5 / 12
TYR B 306
GLY B 273
VAL B 372
LEU B 252
TYR B 299
1.70A20.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6m1d ACE2
(Homo
sapiens)		5 / 10
LEU D 558
MET D 557
TYR D 381
MET D 408
GLY D 377
1.56A16.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6m1d ACE2
(Homo
sapiens)		5 / 12
MET B 408
GLY B 377
LEU B 558
MET B 557
TYR B 381
1.56A16.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6m1d ACE2
(Homo
sapiens)		5 / 11
LEU D 558
MET D 557
TYR D 381
MET D 408
GLY D 377
1.56A16.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6m1d ACE2
(Homo
sapiens)		5 / 10
MET B 408
GLY B 377
LEU B 558
MET B 557
TYR B 381
1.57A16.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6vw1 ACE2
(Homo
sapiens)		5 / 12
MET A 579
GLN A 221
GLY A 220
LEU A 222
TYR A 217
1.64A19.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6vw1 ACE2
(Homo
sapiens)		5 / 11
LEU A 222
TYR A 217
MET A 579
GLN A 221
GLY A 220
1.63A19.30
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.79A
None
NHE  A 202 ( 3.9A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 10
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.74A
None
None
None
None
NHE  A 202 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.74A
None
None
None
None
NHE  A 202 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 10
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.74A
None
None
None
None
NHE  A 202 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.77A
None
None
None
None
NHE  A 202 ( 3.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 12
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.74A
None
NHE  A 202 ( 3.9A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.77A
None
NHE  A 202 ( 3.9A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 12
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6vxs NSP3
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.80A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6w01 URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
MET A 210
GLY A 239
VAL A 304
TYR A 238
PHE A 222
1.67A22.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_H_RAUH400_1
(IMINE REDUCTASE)		6w01 URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 10
MET A 210
GLY A 239
VAL A 304
TYR A 238
PHE A 222
1.65A22.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6w01 URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 10
VAL A 304
TYR A 238
PHE A 222
MET A 210
GLY A 239
1.67A22.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6w01 URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 11
VAL A 304
TYR A 238
PHE A 222
MET A 210
GLY A 239
1.66A22.52
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6w02 NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.71A22.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6w02 NSP3
(SARS-CoV-2)		5 / 12
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.71A22.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6w02 NSP3
(SARS-CoV-2)		5 / 10
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.71A22.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6w02 NSP3
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.75A22.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.75A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.71A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.75A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.73A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.74A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.74A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.73A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 10
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.71A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.71A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 10
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.73A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.77A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.76A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 12
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.71A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6w6y NSP3
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.73A20.27
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 12
MET C 169
SER C 262
VAL C 165
MET C 243
PHE C 304
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 11
VAL C 165
MET C 243
PHE C 304
MET C 169
SER C 262
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 11
VAL C 165
MET C 243
PHE C 304
MET C 169
SER C 262
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_H_RAUH400_1
(IMINE REDUCTASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 10
MET C 169
SER C 262
VAL C 165
MET C 243
PHE C 304
1.73A21.70
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 11
VAL C 165
MET C 243
PHE C 304
MET C 169
SER C 262
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 10
VAL C 165
MET C 243
PHE C 304
MET C 169
SER C 262
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6wcf NSP3
(SARS-CoV-2)		5 / 12
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6wcf NSP3
(SARS-CoV-2)		5 / 10
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6wcf NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6wcf NSP3
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6wcf NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6wcf NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6wcf NSP3
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6wen NSP3
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6wen NSP3
(SARS-CoV-2)		5 / 12
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6wen NSP3
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6wen NSP3
(SARS-CoV-2)		5 / 10
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6wen NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6wen NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6wen NSP3
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6wey NSP3
(SARS-CoV-2)		5 / 12
SER A 284
GLY A 277
VAL A 299
LEU A 247
TYR A 272
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6wey NSP3
(SARS-CoV-2)		5 / 10
SER A 284
GLY A 277
VAL A 299
LEU A 247
TYR A 272
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6wey NSP3
(SARS-CoV-2)		5 / 11
VAL A 299
LEU A 247
TYR A 272
SER A 284
GLY A 277
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6wey NSP3
(SARS-CoV-2)		5 / 11
VAL A 299
LEU A 247
TYR A 272
SER A 284
GLY A 277
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6wey NSP3
(SARS-CoV-2)		5 / 10
VAL A 299
LEU A 247
TYR A 272
SER A 284
GLY A 277
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6wey NSP3
(SARS-CoV-2)		5 / 11
VAL A 299
LEU A 247
TYR A 272
SER A 284
GLY A 277
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6wey NSP3
(SARS-CoV-2)		5 / 10
SER A 284
GLY A 277
VAL A 299
LEU A 247
TYR A 272
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 11
LEU B 291
PHE B 274
TRP B 301
SER A 318
GLY B 287
1.71A
None
None
CL  B 401 ( 4.4A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6wji NUCLEOCAPSID PROTEIN
(SARS-CoV-2)		5 / 10
LEU B 291
PHE B 274
TRP B 301
SER A 318
GLY B 287
1.71A
None
None
CL  B 401 ( 4.4A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 11
VAL A 304
TYR A 238
PHE A 222
MET A 210
GLY A 239
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_H_RAUH400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 10
MET A 210
GLY A 239
VAL A 304
TYR A 238
PHE A 222
1.66A21.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_H_RAUH400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 10
MET B 210
GLY B 239
VAL B 304
TYR B 238
PHE B 222
1.68A21.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 11
VAL B 304
TYR B 238
PHE B 222
MET B 210
GLY B 239
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 11
VAL B 304
TYR B 238
PHE B 222
MET B 210
GLY B 239
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 11
VAL A 304
TYR A 238
PHE A 222
MET A 210
GLY A 239
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 11
VAL A 304
TYR A 238
PHE A 222
MET A 210
GLY A 239
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 11
VAL B 304
TYR B 238
PHE B 222
MET B 210
GLY B 239
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 10
VAL B 304
TYR B 238
PHE B 222
MET B 210
GLY B 239
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
MET B 210
GLY B 239
VAL B 304
TYR B 238
PHE B 222
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 12
MET A 210
GLY A 239
VAL A 304
TYR A 238
PHE A 222
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6wlc URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 10
VAL A 304
TYR A 238
PHE A 222
MET A 210
GLY A 239
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
SER D  80
GLY D  73
VAL D  95
LEU D  43
TYR D  68
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
SER D  80
GLY D  73
VAL D  95
LEU D  43
TYR D  68
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 12
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
SER D  80
GLY D  73
VAL D  95
LEU D  43
TYR D  68
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL D  95
LEU D  43
TYR D  68
SER D  80
GLY D  73
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
VAL D  95
LEU D  43
TYR D  68
SER D  80
GLY D  73
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL D  95
LEU D  43
TYR D  68
SER D  80
GLY D  73
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL D  95
LEU D  43
TYR D  68
SER D  80
GLY D  73
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 10
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6wrh PEPTIDASE C16
(SARS-CoV-2)		5 / 11
VAL A 165
MET A 243
PHE A 304
MET A 169
SER A 262
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6wrh PEPTIDASE C16
(SARS-CoV-2)		5 / 11
VAL A 165
MET A 243
PHE A 304
MET A 169
SER A 262
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6wrh PEPTIDASE C16
(SARS-CoV-2)		5 / 10
VAL A 165
MET A 243
PHE A 304
MET A 169
SER A 262
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_H_RAUH400_1
(IMINE REDUCTASE)		6wrh PEPTIDASE C16
(SARS-CoV-2)		5 / 10
MET A 169
SER A 262
VAL A 165
MET A 243
PHE A 304
1.75A21.64
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6wrh PEPTIDASE C16
(SARS-CoV-2)		5 / 11
VAL A 165
MET A 243
PHE A 304
MET A 169
SER A 262
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6wrh PEPTIDASE C16
(SARS-CoV-2)		5 / 12
MET A 169
SER A 262
VAL A 165
MET A 243
PHE A 304
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL D  95
LEU D  43
TYR D  68
SER D  80
GLY D  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL E  95
LEU E  43
TYR E  68
SER E  80
GLY E  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER E  80
GLY E  73
VAL E  95
LEU E  43
TYR E  68
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL D  95
LEU D  43
TYR D  68
SER D  80
GLY D  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL D  95
LEU D  43
TYR D  68
SER D  80
GLY D  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL E  95
LEU E  43
TYR E  68
SER E  80
GLY E  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER D  80
GLY D  73
VAL D  95
LEU D  43
TYR D  68
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER E  80
GLY E  73
VAL E  95
LEU E  43
TYR E  68
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER E  80
GLY E  73
VAL E  95
LEU E  43
TYR E  68
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER D  80
GLY D  73
VAL D  95
LEU D  43
TYR D  68
1.79A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.78A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL E  95
LEU E  43
TYR E  68
SER E  80
GLY E  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.76A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL E  95
LEU E  43
TYR E  68
SER E  80
GLY E  73
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER D  80
GLY D  73
VAL D  95
LEU D  43
TYR D  68
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL D  95
LEU D  43
TYR D  68
SER D  80
GLY D  73
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER D  80
GLY D  73
VAL D  95
LEU D  43
TYR D  68
1.74A
EDO  D 203 (-3.6A)
None
None
None
EDO  D 202 (-4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER E  80
GLY E  73
VAL E  95
LEU E  43
TYR E  68
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL E  95
LEU E  43
TYR E  68
SER E  80
GLY E  73
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER D  80
GLY D  73
VAL D  95
LEU D  43
TYR D  68
1.76A
EDO  D 203 (-3.6A)
None
None
None
EDO  D 202 (-4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL D  95
LEU D  43
TYR D  68
SER D  80
GLY D  73
1.74A
None
None
EDO  D 202 (-4.3A)
EDO  D 203 (-3.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL E  95
LEU E  43
TYR E  68
SER E  80
GLY E  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER E  80
GLY E  73
VAL E  95
LEU E  43
TYR E  68
1.70A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL D  95
LEU D  43
TYR D  68
SER D  80
GLY D  73
1.74A
None
None
EDO  D 202 (-4.3A)
EDO  D 203 (-3.6A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL E  95
LEU E  43
TYR E  68
SER E  80
GLY E  73
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL E  95
LEU E  43
TYR E  68
SER E  80
GLY E  73
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER D  80
GLY D  73
VAL D  95
LEU D  43
TYR D  68
1.79A
EDO  D 203 (-3.6A)
None
None
None
EDO  D 202 (-4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.77A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.72A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER E  80
GLY E  73
VAL E  95
LEU E  43
TYR E  68
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.74A
None
None
None
EDO  A 204 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.74A
EDO  A 204 ( 4.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.73A
None
None
None
EDO  A 204 (-3.3A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.73A
None
None
None
EDO  A 204 (-3.3A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.75A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.73A
EDO  A 204 (-3.3A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.73A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.76A
EDO  A 204 ( 4.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.76A
None
None
None
EDO  A 204 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.74A
None
None
None
EDO  A 204 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.75A
EDO  A 204 (-3.3A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER C  80
GLY C  73
VAL C  95
LEU C  43
TYR C  68
1.78A
EDO  A 204 ( 4.9A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
SER A  80
GLY A  73
VAL A  95
LEU A  43
TYR A  68
1.77A
EDO  A 204 (-3.3A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 12
SER B  80
GLY B  73
VAL B  95
LEU B  43
TYR B  68
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.75A
None
None
None
EDO  A 204 (-3.3A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL A  95
LEU A  43
TYR A  68
SER A  80
GLY A  73
1.73A
None
None
None
EDO  A 204 (-3.3A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 11
VAL C  95
LEU C  43
TYR C  68
SER C  80
GLY C  73
1.74A
None
None
None
EDO  A 204 ( 4.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_D_RAUD400_1
(IMINE REDUCTASE)		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
VAL B  95
LEU B  43
TYR B  68
SER B  80
GLY B  73
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_G_RAUG400_1
(IMINE REDUCTASE)		7bv2 NSP7
(SARS-CoV-2)		5 / 10
SER C  61
GLN C  63
GLY C  64
VAL C  58
LEU C  20
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_A_RAUA400_1
(IMINE REDUCTASE)		7bv2 NSP7
(SARS-CoV-2)		5 / 11
VAL C  58
LEU C  20
SER C  61
GLN C  63
GLY C  64
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_B_RAUB400_1
(IMINE REDUCTASE)		7bv2 NSP7
(SARS-CoV-2)		5 / 11
VAL C  58
LEU C  20
SER C  61
GLN C  63
GLY C  64
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_C_RAUC400_1
(IMINE REDUCTASE)		7bv2 NSP7
(SARS-CoV-2)		5 / 12
SER C  61
GLN C  63
GLY C  64
VAL C  58
LEU C  20
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_F_RAUF400_1
(IMINE REDUCTASE)		7bv2 NSP7
(SARS-CoV-2)		5 / 10
SER C  61
GLN C  63
GLY C  64
VAL C  58
LEU C  20
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G6S_E_RAUE400_1
(IMINE REDUCTASE)		7bv2 NSP7
(SARS-CoV-2)		5 / 11
VAL C  58
LEU C  20
SER C  61
GLN C  63
GLY C  64
1.68A
None